首页> 外文OA文献 >Practical Method for Preparing Nanosuspension Formulations for Toxicology Studies in the Discovery Stage: Formulation Optimization and in Vitro/in Vivo Evaluation of Nanosized Poorly Water-Soluble Compounds

【2h】

Practical Method for Preparing Nanosuspension Formulations for Toxicology Studies in the Discovery Stage: Formulation Optimization and in Vitro/in Vivo Evaluation of Nanosized Poorly Water-Soluble Compounds

机译：在发现阶段制备纳米血清毒理学研究的实用方法：制剂优化和体外纳米型差的水溶性化合物的含量评价和在体外的体外评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Takao Komasaka; Hisako Fujimura; Toshiaki Tagawa; Akio Sugiyama; Yasunori Kitano;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Practical Method for Preparing Nanosuspension Formulations for Toxicology Studies in the Discovery Stage: Formulation Optimization and in Vitro/in Vivo Evaluation of Nanosized Poorly Water-Soluble Compounds [J] . Komasaka Takao, Fujimura Hisako, Tagawa Toshiaki, Chemical and Pharmaceutical Bulletin . 2014,第11期

机译：在发现阶段准备用于毒理学研究的纳米混悬剂的实用方法：纳米级难溶于水化合物的配方优化和体内/体外评估
2. Practical Method for Preparing Nanosuspension Formulations for Toxicology Studies in the Discovery Stage: Formulation Optimization and in Vitro / in Vivo Evaluation of Nanosized Poorly Water-Soluble Compounds [J] . Takao Komasaka, Hisako Fujimura, Toshiaki Tagawa, Chemical and Pharmaceutical Bulletin . 2014,第11期

机译：在发现阶段准备用于毒理学研究的纳米悬浮制剂的实用方法：纳米级难溶于水化合物的配方优化和体外/体内评估
3. Nanosuspension formulations of poorly water-soluble compounds for intravenous administration in exploratory toxicity studies: in vitro and in vivo evaluation [J] . Fujimura Hisako, Komasaka Takao, Tomari Taizo, Journal of applied toxicology . 2016,第9a10期

机译：纳米苏斯 - 静脉施用性缺水性毒性研究中的纳米溶解化合物：体外和体内评价
4. Formulation of Celecoxib Nanosuspension by Nanoprecipitation Method and Evaluation of its InVivo Anti-inflammatory Activity [C] . Anju Malakani, Abhijit A. Date, Darshana D. Hegde Annual meeting exposition of the Controlled Release Society . 2009

机译：纳米沉淀法制备塞来昔布纳米混悬剂及其抗炎活性的评价
5. (1) Development and in vivo testing of a gastric retention device (GRD) in dogs, (2) Product formulations and in vitro-in vivo evaluation of, (a) immediate release formulation of itraconazole, (b) controlled-release formulation of ketoprofen in adults [D] . Kapsi, Shivakumar G. 1999

机译：（1）在犬中开发胃滞留装置（GRD）并进行体内测试；（2）（a）伊曲康唑的速释制剂，（b）依他康唑的控释制剂的产品配方和体内体外评估成人酮洛芬
6. Eudragit-Based Nanosuspension of Poorly Water-Soluble Drug: Formulation and In Vitro–In Vivo Evaluation [O] . Sarita Kumari Yadav, Shivani Mishra, Brahmeshwar Mishra 2012

机译：水溶性差的药物基于Eudragit的纳米悬浮液：制剂和体内-体外评估
7. >Development and Evaluation of in-situ Nasal Gel Formulations of Nanosized Transferosomal Sumatriptan: Design, Optimization, in vitro and in vivo Evaluation [O] . Mahmoud M Omar, Nermin E Eleraky, Amani M. El Sisi, 2019

机译：>纳米转移族族族族族凝胶配方的发展与评价纳米族族普拉特曲面：设计，优化，体外和体内评价

Practical Method for Preparing Nanosuspension Formulations for Toxicology Studies in the Discovery Stage: Formulation Optimization and in Vitro/in Vivo Evaluation of Nanosized Poorly Water-Soluble Compounds

著录项

引文网络

相似文献

相关主题

期刊订阅